Amaxa Pharma is the leading pharmaceutical company, which specializes in the fields of oncology, hematology, neonatology and immunology. Amaxa’s core competencies are in the area of development and the promotion of pharmaceutical products and services in Eastern Europe and CIS countries (Ukraine, Belarus, Kazakhstan, etc.). Oncology is the primary therapeutic area where Amaxa is driven by its mission to deliver novel and innovative products and services to the patients and doctors. Our operational office is located in Kiev, Ukraine.
Amaxa is the exclusive authorized provider of Caris Molecular Intelligence in Ukraine.